| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4278257 | The American Journal of Surgery | 2015 | 7 Pages |
•This retrospective study shows that thromboembolic events after curative surgery are prevalent in patients with pancreatic cancer, especially within 1 month.•In case of thromboembolism within 1 year of surgery, patients should be cautiously monitored for because of their poor outcomes.
BackgroundInformation regarding postoperative thromboembolism in curatively resected pancreatic cancer is limited. This study aimed to assess the incidence and significance of postoperative thromboembolism.MethodsWe retrospectively reviewed the medical records of 121 curatively resected pancreatic cancer patients. Early and late thromboembolisms were defined as events that occurred within 1 year and after 1 year, respectively.ResultsTwenty-two patients (18%) experienced thromboembolism. Seven thromboembolic events occurred within 1 month (7, 6%), and the incidence rate decreased over time. Ten (63%) of the 16 patients with early thromboembolism experienced thromboembolism before or at the same time as recurrence; however, 5 (83%) of the 6 patients with late thromboembolism experienced recurrence before thromboembolism (P = .005). A significant difference in recurrence-free survival (P = .016) and borderline difference in overall survival (P = .050) were observed between patients with early thromboembolism and others.ConclusionsThromboembolic events after curative surgery are prevalent in pancreatic cancer, especially within 1 month. Thromboembolic events within 1 year of surgery should be cautiously monitored.
